0001729149-23-000013.txt : 20230118 0001729149-23-000013.hdr.sgml : 20230118 20230118185945 ACCESSION NUMBER: 0001729149-23-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230117 FILED AS OF DATE: 20230118 DATE AS OF CHANGE: 20230118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eagan Ewell Patrick CENTRAL INDEX KEY: 0001837950 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38973 FILM NUMBER: 23535535 MAIL ADDRESS: STREET 1: 625 E. KALISTE SALOOM ROAD CITY: LAFAYETTE STATE: LA ZIP: 70508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VIEMED HEALTHCARE, INC. CENTRAL INDEX KEY: 0001729149 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 625 E. KALISTE SALOOM RD. CITY: LAFAYETTE STATE: LA ZIP: 70508 BUSINESS PHONE: 337.504.3802 MAIL ADDRESS: STREET 1: 625 E. KALISTE SALOOM RD. CITY: LAFAYETTE STATE: LA ZIP: 70508 4 1 wf-form4_167408637049022.xml FORM 4 X0306 4 2023-01-17 0 0001729149 VIEMED HEALTHCARE, INC. VMD 0001837950 Eagan Ewell Patrick 625 E. KALISTE SALOOM RD. LAFAYETTE LA 70508 0 1 0 0 General Counsel Common Shares 2023-01-18 4 M 0 1757 A 1757 D Common Shares 2023-01-18 4 D 0 1757 7.77 D 0 D Common Shares 2023-01-18 4 M 0 3514 A 3514 D Phantom Share Units 2023-01-18 4 M 0 1757 0 D 2025-01-18 Common Shares 1757.0 3513 D Restricted Stock Units 2023-01-18 4 M 0 3514 0 D 2025-01-18 Common Shares 3514.0 7027 D Phantom Share Units 2023-01-17 4 A 0 3740 0 A 2026-01-17 Common Shares 3740.0 3740 D Restricted Stock Units 2023-01-17 4 A 0 14962 0 A 2026-01-17 Common Shares 14962.0 14962 D Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date. Exhibit List: -Exhibit 24 Limited Power of Attorney /s/ Jesse Bergeron, Attorney-in-Fact 2023-01-18 EX-24 2 vmdeagansection16poa.htm E EAGAN LIMITED POWER OF ATTORNEY
Ex. 24

LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS

Know all by these presents, that the undersigned hereby constitutes and appoints Jesse Bergeron, Todd Zehnder, and Trae Fitzgerald, or any of them acting singly and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(l)    prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section l6(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

(2)    execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Viemed Healthcare, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section l6(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(3)    do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and timely file such form with the Securities and Exchange Commission and any stock exchange or similar authority;

(4)    seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to each of the undersigned's attorneys-in-fact appointed by this Limited Power of Attorney and approves and ratifies any such release of information; and

(5)    take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this  Limited Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Limited Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

In affixing his or her signature to this Limited Power of Attorney, the undersigned hereby revokes any and all previously executed Powers of Attorney for the same or similar purposes.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 9th day of September, 2022.

/s/ Ewell Patrick Eagan
Ewell Patrick Eagan